Alpha Mark Advisors, LLC Rani Therapeutics Holdings, Inc. Transaction History
Alpha Mark Advisors, LLC
- $231 Million
- Q4 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 500 shares of RANI stock, worth $710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$710% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
42Shares Held
5.93MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.66 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.01 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$700,8891.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$636,8580.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$429,8950.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $34.8M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...